Cyrus Biotechnology Stock
Cyrus Biotechnology builds software tools to accelerate basic research in biotech, pharma, and industrial biotechnology.
Sign up today and learn more about Cyrus Biotechnology Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Cyrus Biotechnology Stock
Cyrus Biotechnology builds software tools to accelerate basic research in biotech, pharma, and industrial biotechnology. Cyrus Bench delivers an enterprise version of the Rosetta molecular modeling and design toolkit, with the associated array of bio-molecular computation tools. It was founded in 2014 and headquartered in Seattle, Washington.
Funding History
| April 2015 | $850K |
|---|---|
| May 2015 | $850K |
| April 2016 | $535K |
| February 2017 | $1.0M |
| July 2017 | $8.0M |
Management
Co-Founder & CTO
Javier Castellanos
Co-Founder & CEO
Lucas Nivon
Co-Founder & Chief Science Officer
Yifan Song
Press
finance - Mar, 4 2024
Cyrus Biotechnology to Present Its Novel IgG-degrading IdeS Enzyme Development Candidates for Autoimmune ...bizjournals - Dec, 7 2021
Cyrus Biotechnology makes acquisition after raising $18Mbiospace - Dec, 6 2021
Cyrus Biotechnology Announces $18M Financing and Acquisition of Orthogonal Biologics to Form an Integrated Software-Driven Pre-Clinical-Stage Drug Discovery Firmnanalyze - Aug, 11 2020
Designing Proteins to be Molecular MachinesEquityZen Recognized As:
